144 related articles for article (PubMed ID: 26040563)
21. ERK5 kinase activity is dispensable for cellular immune response and proliferation.
Lin EC; Amantea CM; Nomanbhoy TK; Weissig H; Ishiyama J; Hu Y; Sidique S; Li B; Kozarich JW; Rosenblum JS
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11865-11870. PubMed ID: 27679845
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cellular functions by the ERK5 signalling pathway.
Wang X; Tournier C
Cell Signal; 2006 Jun; 18(6):753-60. PubMed ID: 16376520
[TBL] [Abstract][Full Text] [Related]
23. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.
Chen H; Tucker J; Wang X; Gavine PR; Phillips C; Augustin MA; Schreiner P; Steinbacher S; Preston M; Ogg D
Acta Crystallogr D Struct Biol; 2016 May; 72(Pt 5):682-93. PubMed ID: 27139631
[TBL] [Abstract][Full Text] [Related]
25. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies.
Alharbi B; Alnajjar LI; Alhassan HH; Khan S; Jawaid T; Abdullaev BS; Alshammari N; Yadav DK; Adnan M; Shamsi A
J Mol Recognit; 2024 Jan; 37(1):e3067. PubMed ID: 37956676
[TBL] [Abstract][Full Text] [Related]
26. The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.
Rovida E; Di Maira G; Tusa I; Cannito S; Paternostro C; Navari N; Vivoli E; Deng X; Gray NS; Esparís-Ogando A; David E; Pandiella A; Dello Sbarba P; Parola M; Marra F
Gut; 2015 Sep; 64(9):1454-65. PubMed ID: 25183205
[TBL] [Abstract][Full Text] [Related]
27. Tumor-suppressive microRNA-206 as a dual inhibitor of MET and EGFR oncogenic signaling in lung squamous cell carcinoma.
Mataki H; Seki N; Chiyomaru T; Enokida H; Goto Y; Kumamoto T; Machida K; Mizuno K; Nakagawa M; Inoue H
Int J Oncol; 2015 Mar; 46(3):1039-50. PubMed ID: 25522678
[TBL] [Abstract][Full Text] [Related]
28. Critical role of aquaporin 3 on growth of human esophageal and oral squamous cell carcinoma.
Kusayama M; Wada K; Nagata M; Ishimoto S; Takahashi H; Yoneda M; Nakajima A; Okura M; Kogo M; Kamisaki Y
Cancer Sci; 2011 Jun; 102(6):1128-36. PubMed ID: 21401805
[TBL] [Abstract][Full Text] [Related]
29. Identification of benzimidazole-based inhibitors of the mitogen activated kinase-5 signaling pathway.
Flaherty PT; Chopra I; Jain P; Yi S; Allen E; Cavanaugh J
Bioorg Med Chem Lett; 2010 May; 20(9):2892-6. PubMed ID: 20382528
[TBL] [Abstract][Full Text] [Related]
30. Activity assays for extracellular signal-regulated kinase 5.
Nakamura K; Johnson GL
Methods Mol Biol; 2010; 661():91-106. PubMed ID: 20811978
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
32. BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma.
Breunig C; Mueller BJ; Umansky L; Wahl K; Hoffmann K; Lehner F; Manns MP; Bantel H; Falk CS
Clin Cancer Res; 2014 May; 20(9):2410-23. PubMed ID: 24573550
[TBL] [Abstract][Full Text] [Related]
33. STAT3 expression, activity and functional consequences of STAT3 inhibition in esophageal squamous cell carcinomas and Barrett's adenocarcinomas.
Timme S; Ihde S; Fichter CD; Waehle V; Bogatyreva L; Atanasov K; Kohler I; Schöpflin A; Geddert H; Faller G; Klimstra D; Tang L; Reinheckel T; Hauschke D; Busch H; Boerries M; Werner M; Lassmann S
Oncogene; 2014 Jun; 33(25):3256-66. PubMed ID: 23912451
[TBL] [Abstract][Full Text] [Related]
34. Extracellular signal-regulated kinase 5 increases radioresistance of lung cancer cells by enhancing the DNA damage response.
Jiang W; Jin G; Cai F; Chen X; Cao N; Zhang X; Liu J; Chen F; Wang F; Dong W; Zhuang H; Hua ZC
Exp Mol Med; 2019 Feb; 51(2):1-20. PubMed ID: 30804322
[TBL] [Abstract][Full Text] [Related]
35. Mutant MAPK7-Induced Idiopathic Scoliosis is Linked to Impaired Osteogenesis.
Zhou T; Chen C; Xu C; Zhou H; Gao B; Su D; Liao Z; Li Y; Yang S; Su P
Cell Physiol Biochem; 2018; 48(3):880-890. PubMed ID: 30032135
[TBL] [Abstract][Full Text] [Related]
36. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR
Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
38. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
39. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
[TBL] [Abstract][Full Text] [Related]
40. Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells.
Carlisle DL; Liu X; Hopkins TM; Swick MC; Dhir R; Siegfried JM
Pulm Pharmacol Ther; 2007; 20(6):629-41. PubMed ID: 17015027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
